ArticleThe Lancet regional health. Europe2024

Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial-authors' reply.

Marc Sapoval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.